Printed on 3/17/2026
For informational purposes only. This is not medical advice.
The Glasgow-Blatchford Bleeding Score (GBS) is a pre-endoscopy risk stratification tool for upper GI hemorrhage. A score of 0 identifies patients at very low risk who may be safely discharged for outpatient endoscopy, reducing unnecessary admissions by ~20%. After endoscopy, use [Rockall Score](/tools/rockall-score) to complete risk stratification. GBS incorporates BUN — assess kidney function with [BUN/Creatinine Ratio](/tools/bun-creatinine-ratio) and [eGFR Calculator](/tools/egfr-calculator). Hepatic disease in GBS: assess severity with [Child-Pugh Score](/tools/child-pugh-score) and [MELD Score](/tools/meld-score).
Formula: BUN (0–6) + Hgb (0–6, sex-adjusted) + SBP (0–3) + HR≥100 (1) + Melena (1) + Syncope (2) + Hepatic (2) + Cardiac (2). Total 0–23.
When a patient presents to the ED with suspected upper GI bleeding (hematemesis, coffee-ground emesis, melena, or hematochezia with upper GI source suspected), immediately order hemoglobin and BUN along with vital signs. The Glasgow-Blatchford Score (GBS) is unique among GI bleeding risk tools because it requires ONLY pre-endoscopy data—no endoscopy or direct visualization is needed. Record the patient's sex, as hemoglobin thresholds differ between males and females in the scoring system. Collect all clinical markers systematically: hemoglobin (g/dL), BUN (mg/dL), systolic blood pressure (mmHg), heart rate (≥100 bpm or not), presence of melena on examination, history of syncope with this bleeding episode, known hepatic disease (cirrhosis, chronic liver disease), and cardiac failure history. Each of these variables contributes points to the total score (0–23). The score can be calculated within minutes of the patient's arrival once initial labs return, enabling rapid triage decisions.
Input all variables into the scoring system with careful attention to the sex-adjusted hemoglobin component. For MALES: Hgb ≥13 g/dL = 0 points, 12–12.9 = 1 point, 10–11.9 = 3 points, <10 = 6 points. For FEMALES: Hgb ≥12 g/dL = 0 points, 10–11.9 = 1 point, <10 = 6 points. This sex adjustment recognizes physiologic differences in normal hemoglobin ranges. BUN scoring: <18.2 mg/dL = 0 points, 18.2–22.3 = 2 points, 22.4–27.9 = 3 points, 28–69.9 = 4 points, ≥70 = 6 points. SBP scoring: ≥110 mmHg = 0 points, 100–109 = 1 point, 90–99 = 2 points, <90 = 3 points. Add 1 point each for heart rate ≥100, melena, and other risk markers (syncope = 2 points, hepatic disease = 2 points, cardiac failure = 2 points). The total score ranges from 0 to 23. The magic number is ZERO. A GBS of 0 means the patient meets all of the following: normal hemoglobin for sex, normal BUN (<18.2), SBP ≥110, HR <100, no melena, no syncope, no hepatic or cardiac disease. This combination identifies patients with <1% risk of needing intervention.
Apply the GBS to triage decisions immediately. **GBS = 0 (very low risk):** These patients can be safely discharged for outpatient endoscopy within 24–72 hours. Multiple studies and international guidelines (NICE, Asia-Pacific Working Group) support this approach. Approximately 20% of ED upper GI bleed presentations have GBS = 0, allowing significant reductions in unnecessary admissions and healthcare costs while maintaining safety. **GBS 1–3 (low risk):** These patients are at low but not negligible risk. Clinical judgment should guide disposition—consider short observation unit stay, next-day endoscopy, or admission depending on social factors (reliable follow-up, proximity to hospital, ability to return if worsening) and comorbidities. **GBS 4–6 (moderate risk):** Admission for inpatient endoscopy is appropriate, as intervention likelihood increases. **GBS ≥7 (high risk):** These patients are very likely to require blood transfusion, urgent endoscopy, or surgical intervention. Initiate resuscitation, consult GI, and admit to appropriate level of care. Document the GBS in the medical record and communicate the risk tier to the patient and consulting services. Use GBS for initial triage, then after endoscopy, calculate the full Rockall Score (which incorporates endoscopic stigmata) to refine rebleeding and mortality risk prediction. The two scores complement each other: GBS for pre-endoscopy triage, Rockall for post-endoscopy prognosis.
Emergency physicians and ED nurses
Apply the Glasgow-Blatchford Score to every patient presenting with hematemesis, coffee-ground emesis, or melena to determine who can be safely discharged for outpatient endoscopy. A GBS of 0 identifies the ~20% of patients who are safe for early discharge, reducing ED overcrowding and unnecessary admissions while maintaining patient safety. Document the score in the ED chart as objective risk stratification, particularly helpful when discussing disposition with GI consultants or admitting teams who may reflexively admit all GI bleeds. Use GBS to prioritize which patients need urgent vs next-day vs outpatient endoscopy.
Hospitalists and observation unit physicians
When patients are placed in observation for GI bleed, use the GBS to refine the monitoring plan and anticipated length of stay. Patients with GBS 1–3 in observation units can often undergo next-morning endoscopy and discharge the same day if findings are low-risk. Patients with GBS ≥6 should be transitioned to inpatient status with anticipated need for transfusion and therapeutic endoscopy. Use GBS to communicate with hospital case managers and utilization review about appropriate level of care, as it provides validated, guideline-supported risk stratification rather than subjective clinical gestalt.
Gastroenterologists and GI fellows
When consulted for upper GI bleeding, use the GBS provided by the ED or admitting team to prioritize endoscopy timing. GBS ≥12 indicates very high risk and warrants emergent endoscopy (within 6–12 hours). GBS 7–11 suggests urgent endoscopy (within 24 hours). GBS 4–6 can proceed with routine inpatient endoscopy. GBS 0–3 may be appropriate for outpatient or next-day endoscopy depending on institutional protocols. Use the score to have objective, guideline-based discussions with ED physicians about whether a patient needs admission or can be safely discharged with outpatient GI follow-up.
Hospital QI teams and clinical pathway designers
Incorporate the Glasgow-Blatchford Score into institutional upper GI bleed clinical pathways to standardize risk stratification and reduce practice variation. Create decision trees where GBS = 0 triggers an outpatient pathway (discharge with GI clinic appointment within 72 hours), GBS 1–3 triggers observation unit or case-by-case decision, and GBS ≥4 triggers admission. Measure outcomes: rates of safe discharge (GBS = 0), 30-day return visits, delayed interventions, and cost savings from reduced admissions. Many institutions have achieved 15–20% reductions in GI bleed admissions after implementing GBS-based protocols without increasing adverse outcomes.
Primary care physicians and urgent care providers
When a patient reports dark stools or possible GI bleeding in an outpatient setting, perform initial risk stratification with GBS if you have access to recent labs (hemoglobin, BUN) and vital signs. Patients with GBS = 0 can potentially be referred for outpatient GI evaluation rather than sent directly to the ED, avoiding unnecessary ED visits and costs. Patients with GBS ≥1 or concerning features (syncope, hemodynamic instability, known liver disease) should be directed to the ED for urgent evaluation. Use GBS to communicate objective risk data when calling GI for outpatient appointments, as 'patient has melena with GBS = 8' conveys urgency more effectively than 'patient has dark stools.'
Medical students, residents, and teaching faculty
Teach the Glasgow-Blatchford Score as the first-line triage tool for upper GI bleeding, emphasizing that it requires no endoscopy and can be calculated immediately in the ED. Contrast with the Rockall Score (which requires endoscopy) to help learners understand the complementary roles: GBS for pre-endoscopy triage and disposition, Rockall for post-endoscopy rebleeding/mortality prediction. Use GBS as a teachable moment about evidence-based resource stewardship—identifying low-risk patients who don't need admission represents high-value care. Quiz learners on the key threshold (GBS = 0 for safe discharge) and the sex-adjusted hemoglobin scoring, as these are commonly tested on board exams and clinical decision-making scenarios.
The most clinically actionable insight from the Glasgow-Blatchford Score is that a score of ZERO identifies patients who can be safely discharged for outpatient endoscopy. Multiple validation studies have shown that GBS = 0 patients have less than 1% risk of needing transfusion, endoscopic therapy, or surgical intervention. To achieve GBS = 0, the patient must have: normal hemoglobin for sex, BUN <18.2 mg/dL, SBP ≥110 mmHg, HR <100, no melena, no syncope, no hepatic disease, and no cardiac failure. This represents approximately 20% of ED upper GI bleed presentations, so using this threshold can reduce admissions by one-fifth while maintaining safety. Many hospitals have implemented 'GBS = 0 discharge pathways' with outpatient GI follow-up scheduled within 48–72 hours, resulting in cost savings and improved patient satisfaction without increasing adverse outcomes.
The Glasgow-Blatchford Score uses different hemoglobin thresholds for males and females, reflecting physiologic differences in normal hemoglobin ranges. For MALES: Hgb ≥13 g/dL scores 0 points, 12–12.9 scores 1 point, 10–11.9 scores 3 points, and <10 scores 6 points. For FEMALES: Hgb ≥12 g/dL scores 0 points, 10–11.9 scores 1 point, and <10 scores 6 points. Missing the sex adjustment can lead to incorrect risk stratification—a female with Hgb 11.5 g/dL would score 1 point (low risk), but the same hemoglobin in a male would score 3 points (moderate risk). Always check the patient's sex before scoring the hemoglobin component. Electronic calculators typically have this adjustment built in, but if calculating manually or teaching, emphasize the sex-specific thresholds.
The BUN (blood urea nitrogen) component of the Glasgow-Blatchford Score captures two important phenomena: (1) GI bleeding itself elevates BUN through the breakdown of blood proteins in the gut, with BUN rising proportionally to the volume of bleeding, and (2) intravascular volume depletion from bleeding causes pre-renal azotemia, further elevating BUN. However, be aware that chronic kidney disease patients may have baseline BUN elevation unrelated to acute bleeding severity, potentially inflating the GBS. Conversely, well-nourished young patients with acute massive bleeding may not yet show BUN elevation if labs are drawn very early (BUN takes hours to rise after a bleed). Despite these limitations, BUN remains one of the strongest predictors in the GBS model, with higher BUN thresholds (≥70 mg/dL) contributing 6 points and strongly predicting need for intervention.
The Glasgow-Blatchford Score and Rockall Score are not competing tools; they are complementary and should be used sequentially in GI bleed management. Use GBS FIRST (pre-endoscopy) for emergency department triage and disposition decisions—it answers the question 'Does this patient need admission and urgent endoscopy?' Then, AFTER endoscopy is performed, calculate the complete Rockall Score (which includes endoscopic stigmata like visible vessel, adherent clot, ulcer size) to predict rebleeding risk and mortality. The Rockall Score is superior for post-endoscopy prognosis, while GBS is superior for identifying very low-risk patients who can be discharged. In practice: GBS in the ED to decide admit vs discharge, Rockall after endoscopy to decide duration of monitoring and PPI therapy.
Syncope (fainting or near-fainting) associated with the GI bleeding episode contributes 2 points to the Glasgow-Blatchford Score, the same weight as hepatic disease or cardiac failure. This heavy weighting reflects that syncope suggests significant acute blood loss causing orthostatic hypotension and cerebral hypoperfusion. When taking the history, explicitly ask: 'Did you feel lightheaded, dizzy, or pass out when this started?' Many patients don't volunteer this symptom unless specifically asked, and missing it can underestimate risk (a patient with otherwise GBS = 0 becomes GBS = 2 if they had syncope). Syncope with GI bleeding nearly always warrants admission and urgent evaluation, as it indicates hemodynamic compromise even if vital signs have since normalized after resuscitation.
Emergency physicians often face pushback when trying to discharge a patient with GI bleeding ('But they're bleeding!'), and conversely may admit patients reflexively even when low-risk. The Glasgow-Blatchford Score provides objective, guideline-supported risk stratification to facilitate these conversations. When calling GI or hospitalist consultants, say 'Patient has melena, hemoglobin 13.2, BUN 16, stable vitals, GBS = 0—international guidelines support outpatient endoscopy for GBS = 0' rather than 'I think this patient is low-risk.' The score converts subjective gestalt into validated, evidence-based risk tiers. Many hospitals have incorporated GBS into admission order sets and clinical pathways, further legitimizing its use as standard of care for disposition decisions.
Patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD) on dialysis often have baseline anemia (hemoglobin 9–11 g/dL) and elevated BUN (especially pre-dialysis BUN of 40–80 mg/dL). When these patients present with possible GI bleeding, their baseline values can result in a high Glasgow-Blatchford Score (e.g., 8–12) even without significant acute bleeding. Clinical judgment is essential in these cases: compare the current hemoglobin to the patient's BASELINE hemoglobin (is it actually lower than usual?) and assess for hemodynamic changes or active bleeding. If the patient's hemoglobin is stable at their baseline and they have no active bleeding symptoms, a high GBS may overestimate acute risk. Consider trends over time rather than absolute values, and consult nephrology or the patient's nephrologist for baseline hemoglobin data.
Melena (black, tarry stools) contributes 1 point to the Glasgow-Blatchford Score, but patient self-report of 'dark stools' is often inaccurate. Many patients describe normal brown stool as 'dark,' or misinterpret side effects of iron supplementation (which causes black but formed, non-tarry stools) as melena. True melena has a distinctive appearance on digital rectal exam: jet-black, sticky, tar-like consistency with a characteristic foul odor due to bacterial degradation of blood. Always perform a digital rectal exam and visualize the stool yourself before scoring melena as present. If the patient reports dark stools but you find no melena on exam, score melena as absent. Conversely, some patients with melena don't recognize it as abnormal, so don't rely on history alone—examination is mandatory for accurate GBS calculation.
Tachycardia (heart rate ≥100 bpm) contributes 1 point to the Glasgow-Blatchford Score and is one of the earliest physiologic compensations for blood loss. A patient can maintain normal blood pressure through compensatory tachycardia and vasoconstriction even after losing 15–30% of blood volume, so HR ≥100 may be the only vital sign abnormality in moderate bleeding. When evaluating a patient with GI bleeding, measure heart rate carefully—some patients have 'borderline' tachycardia (HR 95–105) that may fluctuate with pain or anxiety. If the HR is 100 or above on repeated measurements, score it as present. Also consider orthostatic vital signs: if the patient has a normal seated HR but develops tachycardia ≥100 when standing, this is a red flag for significant blood loss and should be considered when assessing overall clinical stability, even if the seated HR is <100.
While most clinical attention focuses on the lower end of the Glasgow-Blatchford Score (GBS = 0 for safe discharge), the upper end is equally important for prioritizing urgent interventions. Patients with GBS ≥12 are at very high risk for needing immediate intervention (transfusion, endoscopic hemostasis, surgery) and should be triaged for emergent endoscopy within 6–12 hours of presentation. In these patients, initiate massive transfusion protocol consideration, consult GI and surgery early, consider ICU-level monitoring, start IV PPI infusion, and correct coagulopathy aggressively (reverse anticoagulation, transfuse platelets if needed). GBS ≥12 typically corresponds to patients with profound anemia (hemoglobin <8–9 g/dL), elevated BUN (>30–40 mg/dL), hypotension or tachycardia, and possibly hepatic or cardiac comorbidities—this combination predicts high mortality without rapid intervention.
Your Glasgow-Blatchford score stratifies the urgency of intervention needed for upper gastrointestinal bleeding. The most clinically important threshold is a score of 0, which identifies patients at very low risk (less than 1% chance of needing blood transfusion, endoscopic therapy, or surgical intervention). These patients can be safely considered for outpatient management with elective endoscopy. Scores of 1–3 indicate low risk but warrant further clinical judgment. Scores of 4–6 represent moderate risk with increasing likelihood of needing hospital-based intervention. Scores of 7 or above indicate high risk, and these patients are very likely to require transfusion, urgent endoscopy, or surgical intervention.
The score is calculated entirely from clinical and laboratory data available before endoscopy, making it uniquely useful for early triage decisions in the emergency department. Studies have shown that approximately 20% of patients presenting with upper GI bleeding have a GBS of 0 and can be safely managed as outpatients.
Use the Glasgow-Blatchford score in the emergency department when evaluating a patient presenting with suspected upper gastrointestinal bleeding (hematemesis, coffee-ground emesis, melena, or hematochezia with hemodynamic compromise suggesting an upper source). Its primary clinical utility is identifying the subset of patients who are safe for outpatient management, thereby reducing unnecessary hospital admissions.
This score is most valuable as a first-line triage tool before endoscopy is performed. It should be calculated as soon as initial laboratory results (hemoglobin, BUN) and vital signs are available. International guidelines, including those from NICE and the Asia-Pacific Working Group, recommend the Glasgow-Blatchford score for pre-endoscopy risk stratification.
The Glasgow-Blatchford score was derived from a Scottish population and, while validated internationally, may perform differently in populations with different baseline hemoglobin levels (e.g., patients with chronic anemia from renal disease or nutritional deficiency). A chronically anemic patient may score high on the hemoglobin component despite having a minor acute bleed.
The score does not incorporate endoscopic findings, which are important for predicting rebleeding risk. Therefore, it should be complemented by the Rockall score after endoscopy for complete risk stratification. The BUN component uses different scoring thresholds than urea (the original derivation used urea in mmol/L), so ensure appropriate unit conversion. Additionally, certain high-risk features such as anticoagulant use, cirrhosis severity, and active hemodynamic instability are not fully captured by the individual score components.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
Calculate the Rockall score to predict rebleeding and mortality in upper GI hemorrhage. Pre-endoscopy score ≤2: low risk for rebleeding. Post-endoscopy score 0: <5% rebleeding risk.
ClinicalCalculate the Child-Pugh score to classify the severity of chronic liver disease and estimate prognosis. Uses bilirubin, albumin, INR, ascites, and encephalopathy.
ClinicalCalculate the MELD and MELD-Na scores to assess liver disease severity and transplant priority. Uses bilirubin, INR, creatinine, and sodium.
EmergencyCalculate the Shock Index (HR/SBP ratio) for rapid hemodynamic assessment. Normal: 0.5–0.7. Score ≥1.0 indicates hemodynamic compromise; ≥1.4 indicates severe shock requiring immediate intervention.